{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:14:21Z","timestamp":1790673261648,"version":"4.1.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2005,12,7]],"date-time":"2005-12-07T00:00:00Z","timestamp":1133913600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Abdom Imaging"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1007\/s00261-005-0031-3","type":"journal-article","created":{"date-parts":[[2005,12,6]],"date-time":"2005-12-06T13:58:21Z","timestamp":1133877501000},"page":"25-35","source":"Crossref","is-referenced-by-count":62,"title":["Staging and follow-up of gastrointestinal tumors with PET\/CT"],"prefix":"10.1007","volume":"31","author":[{"given":"S. J.","family":"Rosenbaum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Stergar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Antoch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Veit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bockisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"K\u00fchl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,12,7]]},"reference":[{"key":"31_CR1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s002590050197","volume":"25","author":"S Adams","year":"1998","unstructured":"Adams S, Baum R, Rink T, et al. (1998) Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumours. Eur J Nucl Med 25:79\u201383","journal-title":"Eur J Nucl Med"},{"key":"31_CR2","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.gassur.2003.10.003","volume":"8","author":"CD Anderson","year":"2004","unstructured":"Anderson CD, Rice MH, Pinson CW, et al. (2004) Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma. J Gastrointest Surg 8:90\u201397","journal-title":"J Gastrointest Surg"},{"key":"31_CR3","first-page":"357","volume":"45","author":"G Antoch","year":"2004","unstructured":"Antoch G, Kanja J, Bauer S, et al. (2004) Comparison of PET, CT, and dual-modality PET\/CT imaging for monitoring of imatinib (STI571) therapy in patients with gastrointestinal stromal tumors. J Nucl Med 45:357\u2013365","journal-title":"J Nucl Med"},{"issue":"22","key":"31_CR4","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1200\/JCO.2004.08.120","volume":"1","author":"G Antoch","year":"2004","unstructured":"Antoch G, Saoudi N, Kuehl H, et al. (2004) Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET\/CT) for tumor staging in solid tumors: comparison with CT and PET. J Clin Oncol 1(22):4357\u20134368","journal-title":"J Clin Oncol"},{"key":"31_CR5","first-page":"930","volume":"45","author":"N Avril","year":"2004","unstructured":"Avril N (2004) GLUT1 expression in tissue and 18F-FDG uptake. J Nucl Med 45:930\u2013932","journal-title":"J Nucl Med"},{"key":"31_CR6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ctrv.2003.07.004","volume":"30","author":"E Bastiaannet","year":"2004","unstructured":"Bastiaannet E, Groen H, Jager PL, et al. (2004) The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis. Cancer Treat Rev 30:83\u2013101","journal-title":"Cancer Treat Rev"},{"key":"31_CR7","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s00259-002-1097-6","volume":"30","author":"T Beyer","year":"2003","unstructured":"Beyer T, Antoch G, Blodgett T, et al. (2003) Dual-modality PET\/CT imaging: the effect of respiratory motion on combined image quality in clinical oncology. Eur J Nucl Med Mol Imaging 30:588\u2013596","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"31_CR8","first-page":"1369","volume":"41","author":"T Beyer","year":"2000","unstructured":"Beyer T, Townsend DW, Brun T, et al. (2000) A combined PET\/CT scanner for clinical oncology. J Nucl Med 41:1369\u20131379","journal-title":"J Nucl Med"},{"key":"31_CR9","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/S0003-4975(97)00619-X","volume":"64","author":"MI Block","year":"1997","unstructured":"Block MI, Sundaresan SR, Patterson GA (1997) Improvement in staging of esophageal cancer with the addition of positron emission tomography. Ann Thorac Surg 64:770\u2013777","journal-title":"Ann Thorac Surg"},{"key":"31_CR10","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s00432-003-0527-6","volume":"130","author":"B Bohm","year":"2004","unstructured":"Bohm B, Voth M, Geoghegan J, et al. (2004) Impact of positron emission tomography on strategy in liver resection for primary and secondary liver tumors. J Cancer Res Clin Oncol 130:266\u2013272","journal-title":"J Cancer Res Clin Oncol"},{"issue":"suppl P","key":"31_CR11","first-page":"242","volume":"225","author":"I Burger","year":"2002","unstructured":"Burger I, Goerres GW, Schulthess GK, et al. (2002) PET\/CT: diagnostic improvement in recurrent colorectal carcinoma compared to PET alone. Radiology 225(suppl P):242","journal-title":"Radiology"},{"key":"31_CR12","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1097\/00003072-200011000-00010","volume":"25","author":"M Charron","year":"2000","unstructured":"Charron M, Beyer T, Bohnen NN, et al. (2000) Image analysis in patients with cancer studied with a combined PET and CT scanner. Clin Nucl Med 25:905\u2013910","journal-title":"Clin Nucl Med"},{"issue":"5b","key":"31_CR13","first-page":"4357","volume":"23","author":"YK Chen","year":"2003","unstructured":"Chen YK, Kao CH, Liao AC, et al. (2003) Colorectal cancer screening in asymptomatic adults: the role of FDG PET scan. Anticancer Res 23(5b):4357\u20134361","journal-title":"Anticancer Res"},{"key":"31_CR14","first-page":"1797","volume":"44","author":"C Cohade","year":"2003","unstructured":"Cohade C, Osman M, Leal J, Wahl R (2003) Direct comparison of 18F-FDG PET and PET\/CT in patients with colorectal carcinoma. J Nucl Med 44:1797\u20131803","journal-title":"J Nucl Med"},{"key":"31_CR15","first-page":"1784","volume":"40","author":"D Delbeke","year":"1999","unstructured":"Delbeke D, Rose DM, Chapman WC, et al. (1999) Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma. J Nucl Med 40:1784\u20131791","journal-title":"J Nucl Med"},{"key":"31_CR16","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00259-001-0743-8","volume":"29","author":"T Potter De","year":"2002","unstructured":"De Potter T, Flamen P, Van Cutsem E, et al. (2002) Whole-body PET with FDG for the diagnosis of recurrent gastric cancer. Eur J Nucl Med Mol Imaging 29:525\u2013529","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"31_CR17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00006676-200003000-00001","volume":"20","author":"CG Diederichs","year":"2000","unstructured":"Diederichs CG, Staib L, Vogel J, et al. (2000) Values and limitations of 18F-fluorodeoxyglucose-positron-emission tomography with preoperative evaluation of patients with pancreatic masses. Pancreas 20:109\u2013116","journal-title":"Pancreas"},{"key":"31_CR18","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1148\/radiol.2323031065","volume":"232","author":"E Even-Sapir","year":"2004","unstructured":"Even-Sapir E, Parag Y, Lerman H, et al. (2004) Detection of recurrence in patients with rectal cancer: PET\/CT after abdominoperineal or anterior resection. Radiology 232:815\u2013822","journal-title":"Radiology"},{"key":"31_CR19","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1200\/JCO.2000.18.18.3202","volume":"18","author":"P Flamen","year":"2000","unstructured":"Flamen P, Lerut A, Van Cutsem E (2000) Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. J Clin Oncol 18:3202\u20133210","journal-title":"J Clin Oncol"},{"key":"31_CR20","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2214\/ajr.168.2.9016218","volume":"168","author":"FL Flanagan","year":"1997","unstructured":"Flanagan FL, Dehdashti F, Siegel BA (1997) Staging of esophageal cancer with FDG-PET. AJR 168:417\u2013424","journal-title":"AJR"},{"key":"31_CR21","first-page":"80","volume":"71","author":"J Franke","year":"2000","unstructured":"Franke J, Rosenzweig S, Reinartz P, et al. (2000) Value of positron emission tomography (18F-FDG-PET) in the diagnosis of recurrent rectal cancer. Chirurg 71:80\u201385","journal-title":"Chirurg"},{"key":"31_CR22","first-page":"636","volume":"28","author":"LS Freudenberg","year":"2003","unstructured":"Freudenberg LS, Antoch G, Beyer T, et al. (2003) Diagnosis of labia metastasis by F-18 FDG PET and CT fusion imaging in sarcoma follow-up. Clin Nucl Med 28:636\u2013637","journal-title":"Clin Nucl Med"},{"key":"31_CR23","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1097\/00006231-200112000-00002","volume":"22","author":"A Fritscher-Ravens","year":"2001","unstructured":"Fritscher-Ravens A, Bohuslavizki KH, Broering DC, et al. (2001) FDG PET in the diagnosis of hilar cholangiocarcinoma. Nucl Med Commun 22:1277\u20131285","journal-title":"Nucl Med Commun"},{"key":"31_CR24","first-page":"17","volume":"45","author":"I Gayed","year":"2004","unstructured":"Gayed I, Vu T, Iyer R, et al. (2004) The role of 18F-FDG PET in staging and early prediction of response to therapy of recurrent gastrointestinal stromal tumors. J Nucl Med 45:17\u201321","journal-title":"J Nucl Med"},{"key":"31_CR25","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/jjco\/hyf073","volume":"32","author":"S Himeno","year":"2002","unstructured":"Himeno S, Yasuda S, Shimada H (2002) Evaluation of esophageal cancer by positron emission tomography. Jpn J Clin Oncol 32:340\u2013346","journal-title":"Jpn J Clin Oncol"},{"key":"31_CR26","first-page":"213","volume":"44","author":"CL Ho","year":"2003","unstructured":"Ho CL, Yu SC, Yeung DW (2003) 11C-acetate PET imaging in hepatocellular carcinoma and other liver masses. J Nucl Med 44:213\u2013221","journal-title":"J Nucl Med"},{"key":"31_CR27","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1023\/A:1008312726163","volume":"10","author":"M Hoffmann","year":"1999","unstructured":"Hoffmann M, Kletter K, Diemling M, et al. (1999) Positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose (F18-FDG) does not visualize extranodal B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT)-type. Ann Oncol 10:1185\u20131189","journal-title":"Ann Oncol"},{"key":"31_CR28","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1007\/s002590100639","volume":"28","author":"M Hofmann","year":"2001","unstructured":"Hofmann M, Maecke H, Borner R, et al. (2001) Biokinetics and imaging with the somatostatin receptor PET radioligand (68)Ga-DOTATOC: preliminary data. Eur J Nucl Med 28:1751\u20131757","journal-title":"Eur J Nucl Med"},{"key":"31_CR29","first-page":"1177","volume":"41","author":"RH Huebner","year":"2000","unstructured":"Huebner RH, Park JE, Shepard JE, et al. (2000) A meta-analysis of the literature for whole body FDG-PET detection of recurrent colorectal cancer. J Nucl Med 41:1177\u20131189","journal-title":"J Nucl Med"},{"key":"31_CR30","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s002610000159","volume":"26","author":"H Jadvar","year":"2001","unstructured":"Jadvar H, Fischman AJ (2001) Evaluation of pancreatic carcinoma with FDG PET. Abdom Imaging 26:254\u2013259","journal-title":"Abdom Imaging"},{"key":"31_CR31","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/(SICI)1097-0142(19990301)85:5<1026::AID-CNCR3>3.0.CO;2-N","volume":"85","author":"DR Jones","year":"1999","unstructured":"Jones DR, Parker LA Jr, Detterbeck FC (1999) Inadequacy of computed tomography in assessing patients with esophageal carcinoma after induction chemoradiotherapy. Cancer 85:1026\u20131032","journal-title":"Cancer"},{"key":"31_CR32","first-page":"1804","volume":"45","author":"EM Kamel","year":"2004","unstructured":"Kamel EM, Thumsirn M, Truninger K, et al. (2004) FDG Accumulations in the gastrointestinal tract in PET\/CT: correlation with endoscopic and histopathologic results. J Nucl Med 45:1804\u20131810","journal-title":"J Nucl Med"},{"key":"31_CR33","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/bjs.4595","volume":"91","author":"H Kato","year":"2004","unstructured":"Kato H, Miyazaki T, Nakajima M, et al. (2004) Value of positron emission tomography in the diagnosis of recurrent oesophageal carcinoma. Br J Surg 91:1004\u20131009","journal-title":"Br J Surg"},{"issue":"103","key":"31_CR34","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/cncr.20724","volume":"1","author":"H Kato","year":"2005","unstructured":"Kato H, Miyazaki T, Nakajima M, et al. (2005) The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma. Cancer 1;103:148\u2013156","journal-title":"Cancer"},{"issue":"162","key":"31_CR35","first-page":"782","volume":"7","author":"S Keiding","year":"2000","unstructured":"Keiding S, Hansen SB, Rasmussen HH, et al. (2000) Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography. Ugeskr Laeger 7;162:782\u2013785","journal-title":"Ugeskr Laeger"},{"key":"31_CR36","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0168-8278(00)80248-2","volume":"32","author":"MA Khan","year":"2000","unstructured":"Khan MA, Combs CS, Brunt EM, et al. (2000) Positron emission tomography scanning in the evaluation of hepatocellular carcinoma. J Hepatol 32:792\u2013797","journal-title":"J Hepatol"},{"key":"31_CR37","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s00259-003-1297-8","volume":"30","author":"YJ Kim","year":"2003","unstructured":"Kim YJ, Yun M, Lee WJ, et al. (2003) Usefulness of 18F-FDG PET in intrahepatic cholangiocarcinoma. Eur J Nucl Med Mol Imaging 30:1467\u20131472","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"31_CR38","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1148\/radiol.2243011362","volume":"224","author":"K Kinkel","year":"2002","unstructured":"Kinkel K, Lu Y, Both M, et al. (2002) Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis. Radiology 224:748\u2013756","journal-title":"Radiology"},{"key":"31_CR39","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1053\/jhep.2001.23912","volume":"33","author":"R Kluge","year":"2001","unstructured":"Kluge R, Schmidt F, Caca K, et al. (2001) Positron emission tomography with [(18)F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer. Hepatology 33:1029\u20131035","journal-title":"Hepatology"},{"key":"31_CR40","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/bjc.1998.526","volume":"74","author":"AC Kole","year":"1998","unstructured":"Kole AC, Plukker JT, Nieweg OE (1998) Positron emission tomography for staging oesophageal and gastroesophageal malignancy. Br J Cancer 74:521\u2013527","journal-title":"Br J Cancer"},{"key":"31_CR41","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S1536-1632(03)00038-6","volume":"5","author":"J Kowalski","year":"2003","unstructured":"Kowalski J, Henze M, Schuhmacher J, et al. (2003) Evaluation of positron emission tomography imaging using [68Ga]-DOTA-D Phe(1)-Tyr(3)-octreotide in comparison to [111In]-DTPAOC SPECT. First results in patients with neuroendocrine tumors. Mol Imaging Biol 5:42\u201348","journal-title":"Mol Imaging Biol"},{"key":"31_CR42","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.2214\/AJR.04.1337","volume":"185","author":"C Kuehle","year":"2005","unstructured":"Kuehle C, Veit P, Antoch G, et al. (2005) Contrast-enhanced dark lumen PET\/CT and MR colonography in a rodent polyp model\u2014initial results with histopathological correlation. AJR Am J Roentgenol 185:1045\u20131047","journal-title":"AJR Am J Roentgenol"},{"key":"31_CR43","first-page":"1796","volume":"45","author":"R Kumar","year":"2004","unstructured":"Kumar R, Xiu Y, Potenta S, et al. (2004) 18F-FDG PET for evaluation of the treatment response in patients with gastrointestinal tract lymphomas. J Nucl Med 45:1796\u201317803","journal-title":"J Nucl Med"},{"key":"31_CR44","first-page":"1279","volume":"45","author":"AJ Lemke","year":"2004","unstructured":"Lemke AJ, Niehues SM, Hosten N, et al. (2004) Retrospective digital image fusion of multidetector CT and 18F-FDG PET: clinical value in pancreatic lesions\u2014a prospective study with 104 patients. J Nucl Med 45:1279\u20131286","journal-title":"J Nucl Med"},{"key":"31_CR45","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0003-4975(97)00624-3","volume":"64","author":"JD Luketich","year":"1997","unstructured":"Luketich JD, Schauer P, Meltzer CC (1997) The role of positron emission tomography in staging esophageal cancer. Ann Thorac Surg 64:765\u2013769","journal-title":"Ann Thorac Surg"},{"key":"31_CR46","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1259\/bjr.72.858.10560332","volume":"72","author":"D McAteer","year":"1999","unstructured":"McAteer D, Wallis F, Couper G (1999) Evaluation of 18F-FDG positron emission tomography in gastric and oesophageal carcinoma. Br J Radiol 72:525\u2013529","journal-title":"Br J Radiol"},{"key":"31_CR47","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1067\/mge.2000.107727","volume":"52","author":"HR Mertz","year":"2000","unstructured":"Mertz HR, Sechopoulos P, Delbeke D, Leach SD (2000) EUS, PET, and CT scanning for evaluation of pancreatic adenocarcinoma. Gastrointest Endosc 52:367\u2013371","journal-title":"Gastrointest Endosc"},{"key":"31_CR48","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00268-003-7191-5","volume":"28","author":"E Mochiki","year":"2004","unstructured":"Mochiki E, Kuwano H, Katoh H, et al. (2004) Evaluation of 18F-2- deoxy-2-fluoro-D-glucose positron emission tomography for gastric cancer. World J Surg 28:247\u2013253","journal-title":"World J Surg"},{"key":"31_CR49","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/00006231-200403000-00002","volume":"25","author":"Y Nakamoto","year":"2004","unstructured":"Nakamoto Y, Chin BB, Cohade C, et al. (2004) PET\/CT: artifacts caused by bowel motion. Nucl Med Commun 25:221\u2013225","journal-title":"Nucl Med Commun"},{"issue":"21","key":"31_CR50","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1200\/JCO.2003.06.574","volume":"15","author":"K Ott","year":"2003","unstructured":"Ott K, Fink U, Becker K, et al. (2003) Prediction of response to preoperative chemotherapy in gastric carcinoma by metabolic imaging: results of a prospective trial. J Clin Oncol 15(21):4604\u20134610","journal-title":"J Clin Oncol"},{"key":"31_CR51","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s00268-003-7058-9","volume":"27","author":"K Ott","year":"2003","unstructured":"Ott K, Weber WA, Fink U, et al. (2003) Fluorodeoxyglucose-positron emission tomography in adenocarcinomas of the distal esophagus and cardia. World J Surg 27:1035\u20131039","journal-title":"World J Surg"},{"key":"31_CR52","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00117-004-1033-9","volume":"44","author":"PL Pereira","year":"2004","unstructured":"Pereira PL, Clasen S, Boss A, et al. (2004) Radiofrequency ablation of liver metastases. Radiologe 44:347\u2013357","journal-title":"Radiologe"},{"key":"31_CR53","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0009-9260(98)80292-4","volume":"53","author":"SC Rankin","year":"1998","unstructured":"Rankin SC, Taylor H, Cook GJR (1998) Computed tomography and positron emission tomography in the pre-operative staging of oesophageal carcinoma. Clin Radiol 53:659\u2013665","journal-title":"Clin Radiol"},{"key":"31_CR54","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1007\/s002590100626","volume":"28","author":"SN Reske","year":"2001","unstructured":"Reske SN, Kotzerke J (2001) FDG-PET for clinical use. Results of the 3rd German Interdisciplinary Consensus Conference, \u201cOnko-PET III,\u201d 21 July and 19 September 2000. Eur J Nucl Med 28:1707\u20131723","journal-title":"Eur J Nucl Med"},{"key":"31_CR55","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3109\/02841869709001319","volume":"36","author":"M Rodriguez","year":"1997","unstructured":"Rodriguez M, Ahlstrom H, Sundin A, et al. (1997) [18F] FDG PET in gastric non-Hodgkin\u2019s lymphoma. Acta Oncol 36:577\u2013584","journal-title":"Acta Oncol"},{"key":"31_CR56","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1148\/radiol.2312021185","volume":"2311","author":"EM Rohren","year":"2004","unstructured":"Rohren EM, Turkington TG, Coleman RE (2004) Clinical applications of PET in oncology. Radiology 2311:305\u2013332","journal-title":"Radiology"},{"key":"31_CR57","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1055\/s-0038-1625317","volume":"43","author":"F Rosa","year":"2004","unstructured":"Rosa F, Meimarakis G, Stahl A, et al. (2004) Colorectal cancer patients before resection of hepatic metastases. Impact of (18) F-FDG PET on detection of extrahepatic disease. Nuklearmedizin 43:135\u2013140","journal-title":"Nuklearmedizin"},{"key":"31_CR58","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1148\/radiol.2323030985","volume":"232","author":"NG Schaefer","year":"2004","unstructured":"Schaefer NG, Hany TF, Taverna C, et al. (2004) Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging-do we need contrast-enhanced CT? Radiology 232:823\u2013829","journal-title":"Radiology"},{"key":"31_CR59","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s001040170064","volume":"72","author":"PM Schlag","year":"2001","unstructured":"Schlag PM, Amthauer H, Stroszcynski C, Felix R (2001) Einflu\u00df der Positronenemissionstomographie auf die chirurgische Therapieplanung beim colorectalen Rezidivtumor. Chirurg 72:995\u20131002","journal-title":"Chirurg"},{"key":"31_CR60","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.gassur.2004.10.002","volume":"9","author":"C Sperti","year":"2005","unstructured":"Sperti C, Pasquali C, Decet G, et al. (2005) F-18-fluorodeoxyglucose positron emission tomography in differentiating malignant from benign pancreatic cysts: a prospective study. J Gastrointest Surg 9:22\u201329","journal-title":"J Gastrointest Surg"},{"key":"31_CR61","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s00259-002-1029-5","volume":"30","author":"A Stahl","year":"2003","unstructured":"Stahl A, Ott K, Weber WA, et al. (2003) FDG PET imaging of locally advanced gastric carcinomas: correlation with endoscopic and histopathological findings. Eur J Nucl Med Mol Imaging 30:288\u2013295","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"31_CR62","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1196\/annals.1294.027","volume":"1014","author":"A Sundin","year":"2004","unstructured":"Sundin A, Eriksson B, Bergstrom M, et al. (2004) PET in the diagnosis of neuroendocrine tumors. Ann NY Acad Sci 1014:246\u2013257","journal-title":"Ann NY Acad Sci"},{"key":"31_CR63","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1016\/S0959-8049(03)00073-X","volume":"39","author":"S Stroobants","year":"2003","unstructured":"Stroobants S, Goeminne J, Seegers M, et al. (2003) 18FDG-positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec). Eur J Cancer 39:2012\u20132020","journal-title":"Eur J Cancer"},{"key":"31_CR64","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1148\/radiol.2243011214","volume":"224","author":"R Tatlidil","year":"2002","unstructured":"Tatlidil R, Jadvar H, Bading JR, Conti PS (2002) Incidental colonic fluorodeoxyglucose uptake: correlation with colonoscopic and histopathologic findings. Radiology 224:783\u2013787","journal-title":"Radiology"},{"key":"31_CR65","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.2214\/ajr.183.4.1831127","volume":"183","author":"MT Truong","year":"2004","unstructured":"Truong MT, Erasmus JJ, Munden RF, et al. (2004) Focal FDG uptake in mediastinal brown fat mimicking malignancy: a potential pitfall resolved on PET\/CT. AJR 183:1127\u20131132","journal-title":"AJR"},{"key":"31_CR66","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1463-1318.2004.00592.x","volume":"6","author":"ANJ Tutt","year":"2004","unstructured":"Tutt ANJ, Plunkett TA, Barrington SF, Leslie MD (2004) The reole of positron emission tomography in the management of colorectal cancer. Colorectal Dis 6:2\u20139","journal-title":"Colorectal Dis"},{"issue":"suppl","key":"31_CR67","first-page":"424","volume":"225","author":"AD Abbeele van den","year":"2002","unstructured":"van den Abbeele AD, Badawi RD, Cliche JP (2002) Response to imatinib mesylate (Gleevec) therapy in patients with advanced gastrointestinal stromal tumors (GIST) is demonstrated by F-18-FDG-PET prior to anatomic imaging with CT [abstract]. Radiology 225(suppl):424","journal-title":"Radiology"},{"key":"31_CR68","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/S0140-6736(01)06535-7","volume":"358","author":"AT Oosterom van","year":"2001","unstructured":"van Oosterom AT, Judson I, Verweij J, et al. (2001) Safety and efficacy of imatinib (STI 571) in metastatic gastrointestinal stromal tumours: a phase I study. Lancet 358:1421\u20131423","journal-title":"Lancet"},{"key":"31_CR69","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/BF02984475","volume":"18","author":"N Watanabe","year":"2004","unstructured":"Watanabe N, Hayashi S, Kato H, et al. (2004) FDG-PET imaging in duodenal cancer. Ann Nucl Med 18:351\u2013353","journal-title":"Ann Nucl Med"},{"key":"31_CR70","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1200\/JCO.2001.19.12.3058","volume":"19","author":"WA Weber","year":"2001","unstructured":"Weber WA, Ott K, Becker K (2001) Prediction of response to preoperative chemotherapy in adenocarcinomas of esophagogastric junction by metabolic imaging. J Clin Oncol 19:3058\u20133065","journal-title":"J Clin Oncol"},{"key":"31_CR71","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1095-0397(98)00018-1","volume":"1","author":"HW Yeung","year":"1998","unstructured":"Yeung HW, Macapinlac H, Karpeh M, et al. (1998) Accuracy of FDG-PET in gastric cancer. Preliminary experience. Clin Positron Imaging 1:213\u2013221","journal-title":"Clin Positron Imaging"},{"key":"31_CR72","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S1095-0397(99)00035-7","volume":"5","author":"HWD Yeung","year":"1999","unstructured":"Yeung HWD, Macapinlac HA, Mazumdar M (1999) FDG-PET in esophageal cancer: incremental value over computed tomography. Clin Positron Imaging 5:255\u2013260","journal-title":"Clin Positron Imaging"},{"key":"31_CR73","first-page":"690","volume":"44","author":"T Yoshioka","year":"2003","unstructured":"Yoshioka T, Yamaguchi K, Kubota K, et al. (2003) Evaluation of 18F-FDG PET in patients with a, metastatic, or recurrent gastric cancer. J Nucl Med 44:690\u2013699","journal-title":"J Nucl Med"},{"key":"31_CR74","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/apm.1965.64.1.31","volume":"64","author":"PA Lauren","year":"1965","unstructured":"Lauren PA (1965) The two main histologic types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand 64:31\u201349","journal-title":"Acta Pathol Microbiol Scand"}],"container-title":["Abdominal Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-005-0031-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00261-005-0031-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-005-0031-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T16:16:52Z","timestamp":1558714612000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00261-005-0031-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12,7]]},"references-count":74,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["31"],"URL":"https:\/\/doi.org\/10.1007\/s00261-005-0031-3","relation":{},"ISSN":["0942-8925","1432-0509"],"issn-type":[{"value":"0942-8925","type":"print"},{"value":"1432-0509","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,12,7]]}}}